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Health amongst former rugby 
union players: A cross-sectional 
study of morbidity and health-
related quality of life
Madeleine A. M. Davies  1, Andrew D. Judge1, Antonella Delmestri1, Simon P.T. Kemp2, Keith 
A. Stokes3, Nigel K. Arden  1 & Julia L. Newton1
In the general population, physical activity is associated with improved health outcomes. However, 
long-term sports participation may be associated with adverse outcomes, particularly at the elite level. 
The aims of this study were to assess morbidity and health-related quality of life (HrQoL) amongst 
former rugby players, compared to an age-standardised general population sample. A cross-sectional 
study of former elite, male, rugby players (n = 259) was undertaken, and standardised morbidity 
ratios (SMR) calculated, assessing morbidity prevalence relative to English Longitudinal Study of 
Aging participants (ELSA, n = 5186). HrQoL, measured using the EQ-5D, was compared to a Health 
Survey for England (HSE, n = 2981) sample. In SMR analyses of participants aged 50+, diabetes was 
significantly lower amongst former players, (0.28, 95% CI 0.11–0.66), whereas osteoarthritis (4.00, 
95% CI 3.32–4.81), joint replacement (6.02, 95% CI 4.66–7.77), osteoporosis (2.69, 95% CI 1.35–5.38), 
and anxiety (2.00, 95% CI 1.11–3.61) were significantly higher. More problems in HrQoL were reported 
amongst former players within the domains of mobility (p < 0.001), self-care (p = 0.041), usual activities 
(p < 0.001) and pain/discomfort (p < 0.001). Morbidity and HrQoL differ between players and the 
general population, with higher musculoskeletal morbidity and lower diabetes amongst former players. 
The magnitude of musculoskeletal morbidity may warrant proactive osteoarthritis management within 
this population.
Despite the known benefits of exercise and physical activity1, there is an increasing focus on the potential for 
contact sports such as rugby union to be detrimental to physical and neurological health and wellbeing2–8. Based 
on figures for global participation of over 7 million men, women and children in rugby union across more than 
120 countries9, potential alterations in health status and health-related quality of life following participation could 
represent a significant public health benefit or burden.
Little is currently known about morbidity, healthy aging or health related quality of life amongst former rugby 
union (‘rugby’) players2–4,10. Injury incidence within rugby is higher than for non-contact sports, and differs between 
levels of play, with injury most common at the elite levels of play11. A recent meta-analysis suggested that injury 
incidence (>8 days timeloss) during match-play is higher in senior rugby union (81 injuries/1000 hours, 95% CI, 
63–105)12, when compared to semi-professional, (22/1000 hours (95% CI, 20–24), amateur (17/1000 hours, 95% CI, 
15–18) and recreational levels of play (14/1000 hours, 95% CI, 13–16)13. Comparatively, the injury incidence within 
popular non-contact participation sports of elite football and cricket has been reported as 8.0 and 2.7 injuries per 
1000 match hours, respectively14,15. The impact of this higher injury incidence in rugby union on longer-term mor-
bidity and health-related quality of life has not been established to date.
There is limited data on long-term musculoskeletal, neurological and general health outcomes following any 
sports participation, at any level of play5,8,16–19. Informed decision-making for current and future sports partici-
pation requires potential health benefits and adverse outcomes to be considered with a balanced approach, and 
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presented together. This also provides sports governing bodies with a greater body of evidence to support their 
management of player safety. Decreased morbidity following sports participation can promote sport as a means 
of improving health. Where sport is associated with increased morbidity, identifying modifiable risk factors is 
fundamental to facilitating appropriate intervention, and increasing healthy sports participation for the highest 
number of participants. Given the effect of the level of play on injury rates, and more regulated and closely mon-
itored nature of elite sport, health status may be most feasibly influenced at elite levels of sports participation.
The aims of this study were to establish: (1) the prevalence of morbidity and measure health-related quality 
of life within a cohort of former elite, male, rugby players, and (2) to quantify differences in morbidity between 
this sporting population and a representative age-standardised (50years+) general population comparator group.
Methodology
Ethical approval. The study received ethical approval by the University of Oxford Central University 
Research Ethics Committee (MSD-IDREC-C1-2014-020) and was conducted in accordance with the ethical 
standards of the Declaration of Helsinki, with informed consent obtained from all participants or their guardians.
Patient and Public Involvement. Patient and public involvement was undertaken throughout the research 
cycle of this study, with rugby players assisting as consultants co-developing and managing this study20. Current 
and former players were extensively involved throughout the research cycle, with study and questionnaire design, 
study oversight, and questionnaire testing. This process aimed to ensure the questionnaire was accessible and 
intuitive for players, and that it was revised and tested with the target population. Two player involvement fora 
were undertaken with eleven players informing the recruitment strategy, research agenda and functionality of 
online data collection, the process and output of which have been reported elsewhere20.
Study design. A cross-sectional study design was used to assess the prevalence of self-reported 
physician-diagnosed morbidity and health-related quality of life (EQ-5D), within former elite, male, rugby play-
ers. The prevalence of physician-diagnosed morbidity (asthma, diabetes, high blood pressure, heart problems, 
stroke, anxiety, depression, dementia, osteoporosis, osteoarthritis, joint replacement and hip and knee replace-
ment), and reported problems with health-related quality of life (EQ-5D)21, were compared between former 
players and participants in nationally representative population-based studies. Elite players were selected due to 
their well established and preserved alumni playing records, which allowed us to determine the total number of 
potential participants available, and therefore accurate estimates of prevalence. They also represent those at the 
highest risk of injury12, who may have more regulated training, and higher playing exposures, during their career. 
Any health detriments attributable to rugby may therefore be most evident amongst this former elite playing 
population.
Participants. Elite rugby cohorts. Eligible participants included former Oxford and Cambridge University 
players, as well as former English international players. Electronic recruitment of these cohorts through mailing 
lists was staged, and took place between August 2014 and February 2016. UK-based former Oxford players, with 
club-held postal addresses, were also sent a postal questionnaire. Former England player recruitment was through 
a membership organisation, the England Rugby International’s Club (ERIC), of which the membership includes 
approximately 90% of all living, former England International players. ERIC members without email addresses 
were contacted via post where these details were available. Participants were offered the opportunity to partici-
pate by postal questionnaire or telephone interview if preferred, and completion by proxy was permitted where 
requested.
Rugby participants not specifying male sex, retired playing status, or missing age (Fig. 1) were excluded from 
analyses. As rugby became a professional sport in relatively recently, amateur or professional playing status was 
assessed in order to ascertain the number of elite yet amateur participants within the sample, compared with 
those who had played predominantly during the professional era. Study data were collected and managed using 
a secure web application for Research Electronic Data Capture (REDCap)22, hosted at the University of Oxford.
General population cohort. Two datasets were used as representative population-based comparison cohorts, the 
Health Survey for England (HSE) and the English Longitudinal Study of Aging (ELSA). The HSE is an annual 
cross-sectional survey of adults and children living in England, while the ELSA is a longitudinal study which 
contacted HSE respondents from specific years (1998, 1999 and 2001), to participate in a prospective study of 
the health, social, economic circumstances and wellbeing of the English population, aged 50 years and older23. 
Specifically, the 2014 dataset of HSE was used as a cross-sectional, recent representative population-based sur-
vey comparator group for health-related quality of life (EQ-5D)24, whereas the first point of ELSA data collec-
tion (Wave 1), was used as a cross-sectional population-based comparator group, but for multiple morbidities 
(asthma, diabetes, high blood pressure, heart problems, stroke, anxiety, depression, dementia, osteoporosis, oste-
oarthritis, joint replacement and hip and knee replacement). Data from female participants were removed from 
both comparison datasets.
Data sources/measurement.  Participant age was categorised into ten-year age groups (20–29, 30–39, to 
90–99) across all cohorts, and HSE participants outside of the age range of rugby participants (<24 years) were 
excluded (n = 1363), in addition to those who has not fully or partially completed the self-completion question-
naire booklet containing the EQ-5D (Fig. 1). It is important to note that age within HSE is capped such that all 
participants over 90 years of age are coded as 90 years.
The main outcome variables of self-reported, physician-diagnosed asthma, diabetes, high blood pressure, 
heart problems, stroke, anxiety, depression, dementia, osteoporosis, osteoarthritis, and joint replacement, hip 
and knee replacement were collected in rugby cohorts using a custom-designed questionnaire (Supplementary 
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Table S1), and the prevalence of each morbidity estimated Variables were a priori selected as being contributors 
to poor health, and derived as binary variables. Observations which had a ‘don’t know’ response were recoded as 
missing at the disease level, and are indicated in the results section.
Within ELSA, reporting of cardiovascular-related or chronic diseases was assessed with one overarching ques-
tion, extended to up to ten variables if conditions were applicable (see Supplementary Tables S1 and S2). To derive 
a parallel binary heart problems variable in ELSA, we combined the outcomes of angina, heart attack, heart mur-
mur and abnormal heart rhythm. The phrasing of a specific morbidity had some variability between groups, such 
as ‘diabetes’ for rugby participants and ‘diabetes or high blood sugar’ in ELSA and ‘high blood pressure’ in rugby 
and ‘high blood pressure or hypertension’ in ELSA. Consensus on the appropriateness of a comparison given any 
variability in phraseology was discussed and agreed within the research time.
Certain variables collected in HSE (height, weight, BMI) were not collected at Wave 1 of ELSA, and were 
included in analyses after being extracted from Wave 0 of ELSA (participants’ prior HSE questionnaire). Data for 
Wave 0 and Wave 1 were made available through the UK Data Archive.
The EQ-5D was selected as a valid and reliable measurement of health-related quality of life, which has been 
seen to maintain validity and reliability across different geographical and disease populations25–29. The 5-level 
EQ-5D-5L was used for rugby participants due to its increased capacity to discriminate participants with slight, 
moderate or severe problems within a domain (mobility, self-care, usual activities, pain/discomfort and anxiety/
depression). The EQ-5D-5L has also been shown to provide stronger evidence of validity compared with the 
EQ-5D-3L30. A nationally representative 5-level population comparison was not available at the time of analysis, 
and therefore the 2014 HSE, which used a 3-level EQ-5D-3L, was selected as a reference population.
Player sentiment was assessed with novel questions in the custom-designed questionnaire. These questions 
were devised to examine how players reflected on their playing career, and to understand if given the perceived 
benefits and risks of their playing exposure and experiences, whether players felt that they would undertake the 
same participation again, or recommend this to their friends or relatives.
Statistical methods. Statistical analyses were undertaken using Stata 13.1. Descriptive statistics (mean 
(standard deviation) for continuous variables, and number (percentage) for categorical) are presented for the 
former rugby-playing population and the general population comparison groups. Between-group differences for 
ELSA and rugby, and HSE and rugby participants, respectively were tested using unpaired t-tests for continuous 
demographics, and chi-squared tests for categorical variables.
A priori analyses were the estimation of morbidity prevalence, age standardised morbidity ratios31, and 
descriptive statistics for reported problems within each domain of health-related quality of life. The prevalence of 
morbidity in former players (any age), players aged 50+, and ELSA participants was estimated, and then stand-
ardised morbidity ratios were used to demonstrate where morbidity prevalence amongst former players (aged 
50 years+ or 60 years+ for joint replacement), exceeded or was inferior to that of the ELSA general population 
control group. Due to the different EQ-5D tools used (EQ-5D-5L and EQ-5D-3L), responses were dichotomised 
Figure 1. Participant flow from contactable players and comparison population participants to eligibility for 
this study and matched analyses.
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to a ‘no problems’ (EQ-5D ‘1’ scoring) or ‘problems’ (EQ-5D ‘2+’ scoring) variable, for each of the 5 dimensions 
(Fig. 2)21.
Post-hoc sensitivity analyses were included to utilise all player data, by examining significant differences in the 
prevalence of morbidity between the entire cohort of former, male and age-specified players of any age (n = 259), 
and ELSA participants (aged 50+), and testing for significant differences in morbidity between groups using 
logistic regression. Post-hoc chi-squared tests were used to determine if differences in the reported problems 
between players and HSE participants were statistically significant for each dimension of the EQ-5D.
Data availability. The ELSA and HSE datasets that support the findings of this study are freely available but 
were used under license for the current study. Rugby data generated and analysed during the current study are not 
publicly available due to ethical limitations.
Ethical approval. Ethical approval was granted by the University of Oxford Central University Research 
Ethics Committee (Ref. MSD-IDREC-C1-2014-020). Informed consent was provided by all study participants.
Results
Former players. From 1570 contactable players, 319 former Oxbridge and England rugby players, with 
a mean playing exposure of 22.2 years (±5.3), completed this questionnaire study (20.3% response rate). The 
majority of rugby participants responded to the questionnaire as England Rugby Internationals Club (‘ERIC’) 
members (n = 142). Participants who were younger than 50 years (or 60 years for joint replacement) were not 
eligible for age-standardised SMR analyses (Fig. 1).
Demographics. Rugby participants were aged (median (range)) 62.0 (24.2–95.0) years, whereas ELSA par-
ticipants were 64.0 (50.0–99.0) years, and HSE participants 52.0 (24.0–90.0) years. The majority of participants 
identified as white. The mean BMI of all cohorts was > 25 kgm2 (28.1kgm2, 24.5 kgm2 and 27.0kgm2 for rugby, 
ELSA and HSE participants, respectively). Smoking, marital and employment status are summarised below 
(Table 1). Rugby participants were predominantly amateur players (83.6%) whose average total years of match 
play was over two decades (22.2 y).
Prevalence of morbidity. The prevalence of morbidity differed between the complete cohort of rugby par-
ticipants (n = 259) and ELSA participants aged 50 and above (Table 2). The most prevalent morbidities amongst 
rugby participants were osteoarthritis (60%), high blood pressure (28%) and joint replacement (24%), whereas 
the most prevalent morbidities amongst ELSA participants were high blood pressure (37%), heart problems 
(24%) and osteoarthritis (15%).
Health-related quality of life. Full results for the EQ-5D amongst rugby participants and HSE partici-
pants are shown in Supplementary Table S3. The highest numbers of problems were reported for pain/discom-
fort (78.3% and 32.6%, for rugby participants and HSE participants respectively), followed by mobility (47.4% 
and 18.5%, respectively). When EQ-5D domains were dichotomised to problems (2+) or no problems (1) per 
domain, for either the EQ-5D-5L or EQ-5D-3L, reported problems were seen to be twice as prevalent for rugby 
participants in comparison with the HSE reference population, within the domains of mobility, pain/discomfort 
and usual activities (Fig. 2). Chi-squared analyses demonstrated significant between-group differences within 
the domains of mobility (p = < 0.001), self-care (p = 0.041), usual activities (p = < 0.001) and pain/discomfort 
(p = < 0.001).
Standardised morbidity ratios. Musculoskeletal morbidities of osteoarthritis (4.00, 95% CI 3.32 to 4.81), 
osteoporosis (2.69, 95% CI 1.35 to 5.38), hip replacement (6.42, 95% CI 4.69 to 8.79) and knee replacement (5.64, 
95% CI 3.72–8.57) were significantly increased amongst rugby participants (Table 3). Anxiety was also seen to be 
more likely amongst rugby participants (2.00, 95% CI 1.11 to 3.61). Diabetes was significantly reduced amongst 
rugby participants (0.28, 95% CI 0.11 to 0.66). Asthma, high blood pressure, heart problems and stroke were 
reduced (SMR < 1), but did not reach statistical significance.
Figure 2. Percentage EQ-5D problems per dimension amongst HSE and rugby participants.
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Characteristic Rugby (N = 259) ELSA (N = 5186) p-value HSE (N = 2981) P-value
Age (yr)
 Mean (SD) 259 60.1 ± 16.1 5186 64.9 ± 10.0 <0.01 2981 53.4 ± 16.3 <0.01
 Median (range) 259 62.0 (24.2–95.0) 5186 64.0 (50.0–99.0) 2981 52.0 (24.0–90.0)
   20–29 5 (2%) 0 224 (8%)
   30–39 31 (12%) 0 460 (15%)
   40–49 37 (14%) 0 603 (20%)
   50–59 50 (19%) 1916 (37%) 553 (19%)
   60–69 44 (17%) 1611 (31%) 579 (19%)
   70–79 64 (25%) 1174 (23%) 373 (12%)
   80–89 27 (10%) 447 (9%) 171 (6%)
   90–99 1 (1%) 38 (1%) 18 (1%)
White race – no. (%) 204 199 (98%) 5148 4973 (97%) 0.46 2978 2713 (91%) <0.01
Height (m) 252 1.82 ± 0.07 4856 1.73 ± 0.07 <0.01 2963 1.77± 0.07 <0.01
Weight (kg) 254 94.0 ± 15.2 4739 82.2 ± 13.1 <0.01 2912 84.2 ± 14.7 <0.01
BMI (kg/m2)* 249 28.1 ± 3.7 4720 27.5 ± 3.8 <0.02 2896 27.0 ± 4.3 <0.01
 Underweight (<18.5) 0 25 (1%)
 Normal range (18.2–24.9) 41 (17%) 989 (34%)
 Pre-obesity (25.0–29.9) 148 (59%) 1272 (44%)
 Obese Class I (30.0–34.9) 50 (20%) 467 (16%)
 Obese Class II (35.0–39.9) 8 (3%) 114 (4%)
 Obese Class III (>40.0) 2 (1%) 29 (1%)
Ever smoker 257 25 (10%) 5104 3824 (74%) <0.01 2981 1832 (61%) <0.01
Marital status: 207 5185 <0.01 2979 <0.01
 Single/never married 6 (3%) 324 (6%) 417 (14%)
 Married 171 (83%) 3916 (76%) 1814 (61%)
 Separated 1 (1%) 64 (1%) 56 (2%)
 Divorced 14 (7%) 399 (8%) 200 (7%)
  Widowed 12 (6%) 482 (9%) 136 (4%)
 Other 3 (2%) 0 356 (12%)
Amateur status 256 214 (84%)
Total years of play
 Mean (SD) 245 22.2 ± 5.3
 Median (range) 245 22.0 (10.0–43.0)
Employed or retired1 251 246 (98.0%)
Table 1. Descriptive characteristics of the rugby and ELSA cohorts. The results are expressed as mean (±SD) or 
number (%). *Derived from self-reported height and weight: BMI = (weight in kilograms/(height in meters × 
height in meters)). 1Derived from ‘Are you currently employed’? and ‘If no, are you retired’?
Morbidity
Rugby players (n = 259) vAged 
24–95
Rugby players (n = 186) Aged 
50–95 ELSA (n = 5186) Aged 50–99
Number of 
respondents Number (%)
Number of 
respondents Number (%)
Number of 
respondents Number (%)
Asthma 245 24 (10%) 176 11 (6%) 5184 524 (10%)
Diabetes 238 5 (2%) 171 5 (3%) 5184 464 (9%)
High blood pressure 245 68 (28%) 178 66 (36%) 5184 1905 (37%)
Heart problems 241 43 (18%) 174 40 (22%) 5184 1236 (24%)
Stroke 198 6 (3%) 148 6 (3%) 5184 264 (5%)
Anxiety 242 18 (7%) 174 11 (6%) 5184 175 (3%)
Depression 241 15 (6%) 174 9 (5%) 5184 218 (4%)
Dementia 197 2 (1%) 147 2 (1%) 5184 36 (1%)
Osteoporosis 240* 9 (4%) 174 8 (4%) 5184 76 (1%)
Osteoarthritis 253 152 (60%) 184 112 (60%) 5017 729 (15%)
Joint replacement 253 60 (24%) 184 59 (32%) 3181● 202 (6%)
Hip replacement 254 39 (15%) 185 39 (21%) 3181● 126 (4%)
Knee replacement 254 23 (9%) 185 22 (12%) 3181● 80 (3%)
Table 2. The prevalence of morbidity in rugby players and ELSA participants *denotes participant(s) ‘don’t 
know’ response recoded as missing. ●60+ for joint replacement variables.
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Sensitivity Analyses. As matching to ELSA involved selecting an older subgroup of the recruited former 
playing population, logistic regression was used to examine the differences between the entire cohort (n = 259) of 
rugby participants (aged 24 to 95) and the ELSA population (aged 50 to 99). This analysis was then adjusted for 
age. In the entire rugby cohort (n = 259), diabetes, high blood pressure and heart problems were significantly less 
prevalent amongst rugby participants than ELSA participants aged 50+, in unadjusted analyses. When adjusted 
for age, this significant difference remained for diabetes and high blood pressure. Joint replacement, hip and knee 
replacement, osteoarthritis, osteoporosis and anxiety were significantly more prevalent before and after adjust-
ment for age (Table 4).
Player sentiment. Rugby participants were asked whether considering the risks and benefits of their pre-
vious participation in rugby, they would do the same again, and 94% of rugby participants either agreed, or 
strongly agreed. Rugby participants were also asked whether considering the benefits and risks of their previous 
participation in rugby, would they recommend the sport to their friends and family, and 78% agreed or strongly 
agreed (Table 5).
Discussion
Main findings.  Our study, based on data from over 250 former elite rugby players, found differences in mor-
bidity and health-related quality of life between rugby participants and ELSA participants. Amongst participants 
aged 50 and above, age-matched standardised morbidity ratios show diabetes to be significantly lower amongst 
rugby participants (0.28, 95% CI 0.11–0.66), whereas osteoporosis (2.69, 95% CI 1.35–5.38), osteoarthritis (4.00, 
95% CI 3.32–4.81), joint replacement (6.02, 95% CI 4.66–7.77), and site-specific joint replacement at the hip 
(6.42, 95% CI 4.69–8.79) and knee (5.64, 95% CI 3.72–8.57) are significantly more likely amongst rugby partici-
pants than ELSA participants.
Problems with health-related quality of life were most highly reported for pain/discomfort (73.8%) and mobil-
ity (47.4%). For the domains of mobility, pain/discomfort and usual activities, reported problems were twice as 
prevalent in rugby participants.
Sensitivity analyses using logistic regression demonstrated decreased morbidity for diabetes, high blood pres-
sure and heart problems amongst the complete (any age) rugby and ELSA samples. When adjusted for age, a 
significant difference remained for diabetes and high blood pressure. Logistic regression analyses between the 
complete all age rugby and ELSA samples also demonstrated higher odds of joint replacement, osteoarthritis, 
osteoporosis and anxiety amongst rugby participants. When adjusted for age, this significant difference remained 
for all morbidities except anxiety.
Strengths and limitations. Strengths of this study include the English International playing cohort and 
comparator population surveys being nationally representative, the consistency between self-reported out-
comes across all cohorts and the comparability of question phraseology (see Supplementary Table S1). The 
cross-sectional methodology has allowed the measurement of multiple morbidities, in order to present a relatively 
comprehensive overview of health within this population. Limitations of this approach include reduced capacity 
to infer causality in estimated associations, and self-reported outcomes, as less robust measures of morbidity than 
direct measurement. However, this was consistent between ELSA and rugby data collection.
Morbidities may be diagnosed at any age, and our cross-sectional approach limits discussion of current mor-
bidity, compared with lifetime morbidity. The prevalence of morbidity outcomes may also change over time in 
any population, and be influenced by current societal, economic and environmental factors, which we are una-
ble to account for in this analysis. The English Longitudinal Study of Aging is one of few studies that examines 
the prevalence of multiple physician-diagnosed morbidities required for this comparison, however this meant 
Morbidity Prevalence
Expected 
prevalence* SMR 95% CI
Asthma 11 (6%) 18 (10%) 0.60 0.33 to 1.08
Diabetes 5 (3%) 18 (10%) 0.28 0.11 to 0.66
High blood pressure 66 (36%) 71 (38%) 0.92 0.73 to 1.18
Heart problems 48 (22%) 50 (27%) 0.80 0.59 to 1.09
Stroke 6 (3%) 11 (6%) 0.52 0.23 to 1.16
Anxiety 11 (6%) 6 (3%) 2.00 1.11 to 3.61
Depression 9 (5%) 7 (4%) 1.34 0.70 to 2.58
Dementia 2 (1%) 1 (1%) 1.40 0.35 to 5.61
Osteoporosis 8 (4%) 3 (2%) 2.69 1.35 to 5.38
Osteoarthritis 112 (60%) 28 (15%) 4.00 3.32 to 4.81
Joint replacement● 59 (32%) 10 (5%) 6.02 4.66 to 7.77
Hip replacement● 39 (21%) 6 (3%) 6.42 4.69 to 8.79
Knee replacement● 22 (12%) 4 (2%) 5.64 3.72 to 8.57
Table 3. Age-matched standardised morbidity ratios for rugby players aged 50+ (n = 186) against an ELSA 
reference population (n = 5186). *Denotes n to the nearest whole number. ●Based on HSE members 60+.
www.nature.com/scientificreports/
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limiting SMR analyses to rugby participants aged 50 and above. The sensitivity analysis using all subjects, to allow 
the inclusion of morbidities amongst younger rugby participants, confirmed the findings. Many of the assessed 
morbidities will be highly associated with age, and therefore a reference population with detailed morbidity data 
but a more similar age range and distribution would have been favourable. Comorbidities are also increasingly 
common in developed countries32, and this study has not explored comorbidity, interactions between morbidi-
ties, or between morbidity and health related quality of life, due to a lack of statistical power.
The elite population selected, as University attendees and International sports participants, may be of a higher 
socioeconomic status than the majority of the rugby playing population, and socioeconomic status is known to 
be positively associated with health33. However, these populations were selected due to their strong alumni data-
base, which permitted us to accurately quantify response rate, and hence prevalence data. The response rate for 
this study was 20.3%, with a substantially higher response from ERIC members (response rate 40%), than from 
Oxbridge players. This response rate is lower than several population-based longitudinal studies34,35, and more 
aligned with harder to reach groups. Due to ethical limitations, we were unable to determine differences in age or 
socioeconomic status between respondents and non-respondents, to determine how representative respondents 
were of the entire cohorts. This may have resulted in a differential bias, should players who have responded be 
those who are older members of the lists, with a higher prevalence of morbidity than the whole target population 
available to participate on the lists. However, as a study of multiple general health outcomes, this should not dif-
ferentially affect our overall morbidity profile for players compared with population-based survey participants, 
as whilst it is possible people with more illness may respond, this should affect all morbidities equally. Whilst 
the study presents initial findings of morbidity within this population, the results should be considered with the 
potential for a higher response from less healthy rugby-playing individuals. Study findings were confirmed in 
each cohort before this data was merged, however, and findings within the ERIC group, with a higher response 
rate, were similar to those of Oxbridge participants.
Morbidity and health-related quality of life amongst former elite participants may not be generalisable to the 
entire playing population. The majority of players do not play at the elite, particularly representative level, and 
these results may not represent morbidity amongst other playing populations, such as recreational players. This 
study was undertaken to identify initial health differences, and further study will need to determine the relevance 
of morbidity in elite participants, to that of recreational; and amateur players, with lower lifetime playing expo-
sures. Female participants have been excluded from analyses due to the small number of female participants, who 
will have different sex-determined inherent risks of morbidity. This sample of rugby participants is also from 
Morbidity
All rugby players against ELSA sample
Unadjusted logistic regression Logistic regression adjusted for age
Odds ratio (CI) Odds ratio (CI)
Asthma 0.97 (0.63 to 1.49) 0.91 (0.59 to 1.41)
Diabetes 0.22 (0.09 to 0.53) 0.24 (0.10 to 0.58)
High blood pressure 0.66 (0.50 to 0.88) 0.72 (0.54 to 0.96)
Heart problems 0.70 (0.50 to 0.97) 0.77 (0.55 to 1.10)
Stroke 0.58 (0.26 to 1.32) 0.60 (0.26 to 1.38)
Anxiety 2.30 (1.39 to 3.80) 1.83 (1.08 to 3.09)
Depression 1.51 (0.88 to 2.60) 1.11 (0.63 to 1.96)
Dementia 1.47 (0.35 to 6.14) 1.56 (0.37 to 6.53)
Osteoporosis 2.91 (1.49 to 5.70) 3.22 (1.64 to 6.33)
Osteoarthritis 8.85 (6.80 to 11.52) 10.12 (7.71 to 13.29)
Joint replacement 4.58 (3.32 to 6.33) 7.79 (5.47 to 11.11)
Hip replacement 4.40 (2.99 to 6.46) 6.86 (4.56 to 10.33)
Knee replacement 3.86 (2.38 to 6.25) 5.77 (3.49 to 9.52)
Table 4. Between-cohort analyses of morbidity using the complete playing cohort (n = 259).
1. Strongly agree 2. Agree 3. Undecided
4. 
Disagree
5. Strongly 
disagree
Considering the benefits and risks of my previous 
participation in rugby, I would do the same again. 
(n = 204)
167 (82%) 26 (13%) 9 (4%) 1 (1%) 1 (1%)
Considering the benefits and risks of my previous 
participation in rugby, I would recommend this to my 
children, relatives or close friends. (n = 204)
91 (45%) 67 (33%) 29 (14%) 13 (6%) 4 (2%)
1. Dramatically 2. Somewhat 3. Undecided 4. Not really
5. Not at 
all
Did your rugby career enrich your life? (n = 206) 178 (86%) 27 (13%) 0 1 (1%) 0
Table 5. Player reflections on their playing career given their experience for a subset of participants.
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the amateur era of rugby, and modern professional rugby is widely accepted to differ in terms of the nature and 
frequency of game events, its duration (ball in play time) and player physique11.
For rarer morbidities (<5% prevalence) in this relatively small sample, drawing robust inferences is challeng-
ing. Morbidities such as osteoporosis and dementia with low cases and wider confidence intervals will require 
further study in order to validate and support these findings. However, these results indicate the morbidities that 
most strongly differ between rugby participants and the general population, following participation in elite rugby. 
Future study should seek to understand the extent to which these differences in morbidity are sustained for rec-
reational players, and in the modern era of the sport.
Parallel phraseology between comparator groups and players is considered to be a strength of this study. 
However, even very minor alterations in phraseology will affect morbidity sensitivity and specificity. The defini-
tion of diabetes in ELSA involved ‘diabetes or high blood pressure’ and high blood pressure in ELSA was ‘high 
blood pressure or hypertension’. These broader and more inclusive definitions will have increased the prevalence 
of these conditions amongst ELSA participants in comparison with rugby participants, and may therefore have 
inflated SMR results in favour of worse health in the comparator group. This may have influenced our results and 
should be considered when interpreting diabetes and hypertension results, as we are unable to further quantify 
this potential bias. A further consideration for the interpretation of results between cohorts is the difference 
observed between demographics for rugby participants and the general population samples. Differences par-
ticularly in age, smoking status and BMI, may affect the prevalence of morbidities, and therefore health sta-
tus. Analyses were adjusted for age and weight, however not for smoking status, which may have particularly 
affected cardiac morbidities. However this study was designed to assess overall health status within former elite 
rugby players, and cannot feasibly control for all potential confounder for all morbidities, and lifestyle factors are 
acknowledged to be different between former elite rugby players and the general population.
Osteoarthritis. Physician-diagnosed OA was four times higher and any joint replacement was six times 
higher for former elite rugby participants compared with the ELSA population. Rugby participants were asked, 
“Have you ever been told you have wear and tear, degeneration or Osteoarthritis by a doctor?” and including a 
broader definition of ‘wear and tear’ amongst this sporting population will have increased reporting of this out-
come. However, ‘wear and tear’ terminology has been traditionally associated with OA36. OA has been established 
as a potential outcome following sporting injuries17,18,37, and this study presents initial evidence of a significant 
burden of lower limb OA in this population.
The extent of this difference may support proactively managing OA risk in former elite playing populations. 
Initial OA management includes guidance on OA care, education on the condition and non-pharmacological 
management with exercise and weight loss38. Weight management and exercise are components of a healthy 
lifestyle, and the emphasis of this to players transitioning from the game, and physicians in general practice, may 
increase awareness and begin to manage this increased 4- to 6-fold increased risk of OA outcomes.
Cardiovascular.  Cardiovascular morbidity differed between sensitivity analyses of the complete (any age) 
cohort and SMR analyses matched on age. In the complete cohort, heart problems and high blood pressure were 
significantly reduced in univariable analyses, and high blood pressure remained significantly reduced in regres-
sion analyses when adjusted for age, however no cardiovascular morbidities were reduced in SMR analyses. These 
differing results may reflect the increased power afforded by the complete cohort analysis, as suggested by similar 
SMRs, but we cannot exclude that unmatched younger rugby participants may have biased the association. The 
findings are consistent with previous literature showing that regular physical activity reduces the risk of cardio-
vascular disease and hypertension39–43.
Diabetes. Diabetes is significantly reduced in former elite rugby participants. Diabetes is associated with 
many chronic health conditions, and predisposes individuals to cardiovascular disease, blindness, kidney disease 
and depression44. Risk factors for diabetes include age, race, family history of the condition, smoking, obesity and 
physical inactivity45. Whilst the rugby participants are younger than the ELSA sample, the standardised morbid-
ity ratio was matched on age and as such, age could not explain this reduction. The majority of rugby and ELSA 
participants were white (96.6%), and therefore racial differences should also not explain the association. Although 
Type 2 diabetes is strongly associated with adiposity46, similar levels of obesity were seen between rugby partic-
ipants and ELSA participants in this study. However, adiposity is assessed using BMI, which may not be a good 
measure of obesity in sportspersons as it may reflect high lean muscle mass rather that high fat mass: using World 
Health Organisation BMI categorisation, 65% of players within the semi-finalist teams of the 2003 Rugby World 
Cup were classified as overweight, and 25% as obese47. As there were no direct measures of adiposity collected for 
this population, it is plausible that a comparable BMI between rugby participants and the general population may 
disguise differences in somatotype and body composition, which may be associated with diabetes risk.
Sporting and non-sporting physical activity has been associated with reduced type 2 diabetes prevalence48, 
and, moderate intensity physical activity has been associated with approximately 30% reduction in diabetes risk 
(RR 0.69), sustained as a 17% reduction in risk after adjustment for BMI49. A higher lifetime physical activ-
ity is most likely the main contributor to the decreased risk of diabetes observed amongst rugby participants. 
Unfortunately, this cannot be confirmed as data on current activity was not available in both cohorts.
Osteoporosis. The elevated SMR for osteoporosis needs further investigation. Previous studies have found 
higher total body bone mineral density and regional bone mineral density amongst rugby players, and physi-
cal activity has been shown to be preventative of osteoporosis50–52, and therefore a lower bone mineral density 
and osteoporosis in later life is counterintuitive. As former elite sport participants, players may have increased 
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access to privatised healthcare, and therefore increased access to routine investigation such as Dual-energy X-ray 
absorptiometry (DXA) which may, through surveillance bias, increase osteoporosis diagnoses. It is also worth 
noting that osteoporosis was the only outcome across which several participants had declared an uncertainty 
in reporting. Any ‘don’t know’ responses were recoded as missing in analyses, and therefore will have not influ-
enced this analysis directly, however may represent uncertainty around the term or recall of the diagnosis of 
osteoporosis.
Anxiety. Anxiety was found to be twice as prevalent amongst rugby participants as ELSA participants, how-
ever 85% of participants reported no problems with anxiety or depression, measured using the EQ-5D. This 
difference may be due to the different recall period between the EQ-5D and medical history. The focus of the 
EQ-5D is on current health, stating for example ‘I am not anxious or depressed’ or ‘I am moderately anxious or 
depressed’. The difference between anxiety results may demonstrate that whilst rugby participants have previously 
been diagnosed with anxiety, and the rugby participants have a higher likelihood of physician-diagnosed anxiety 
than the reference population, this is a past diagnosis and rugby participants are not currently experiencing anx-
iety. All morbidities assessed were lifetime prevalence (‘ever’) physician-diagnosed morbidity and as such, may 
not be current.
In sensitivity analyses, anxiety was seen to be more likely before being adjusted for age in the complete cohort, 
and demonstrated a higher prevalence in the whole cohort as opposed to those aged 50 and above included in 
SMR analyses. This may suggest that anxiety is either affecting or being diagnosed more frequently amongst 
younger rugby participants. Potential explanations for this higher likelihood of anxiety may be character traits 
within elite athletes contributing to poorer mental health post-retirement, or distressing effects of career transi-
tion seen following sports participation at the elite level53,54, affecting mental health. Former elite rugby partic-
ipants in this study will have transitioned from elite sport, which may have financial and psychological affects 
on players. Retirement amongst the sporting cohort may have been at an earlier age than for ELSA participants, 
which may affect both financial and health status, and have influenced anxiety at this time. Anxiety related mental 
health problems amongst University students have been previously discussed as an area of concern; more than 
depression and stress55. Therefore the University alumni in this study may be more predisposed to having a pre-
vious diagnosis of anxiety, during their life course.
Other morbidities. Morbidities that did not significantly differ between cohorts in SMR or sensitivity analy-
ses were asthma, stroke, depression and dementia. Stroke, dementia and depression were both rare outcomes and 
given the sample size, there may not be sufficient cases in each group to detect differences.
There is the potential for these findings to be translated into increased provision of population-wide targeted 
player welfare for former elite rugby players. Participants have demonstrated some health deficits and some health 
advantages when compared to an age-matched representative general population sample, and strategies such as 
OA-management and advice may be feasible to implement and help improve health status for retiring elite play-
ers, and players in the future.
Conclusions
This study has substantially expanded current knowledge in long-term health and players of rugby union. Future 
research needs to examine the application of these findings to modern rugby, female participants and lower levels 
of participation and sporting exposure. Potentially modifiable risk factors that may be associated with the devel-
opment of negative health outcomes need to be identified in this population.
The magnitude of musculoskeletal morbidity in this population warrants proactive education and manage-
ment within this at-risk sporting population. Further research in other sports may encourage the adoption of a 
more proactive approach to long-term health within elite and recreational sports, encouraging healthy sporting 
activity for all participants.
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